Veradigm | MDRX - Equity Capital And Reserves


Veradigm reported $1.02B in Equity Capital and Reserves for its fiscal quarter ending in December of 2022.





Equity Capital And Reserves Change Date
Alcidion AUD 89.64M 1.84M Dec/2025
Ambu A/S DKK 6.1B 65M Mar/2026
Amplifon EUR 1.51B 436.98M Jun/2026
Cardinal Health USD -2.88B 51M Jun/2026
Centene USD 22.56B 1.14B Jun/2026
Charles River Laboratories USD 2.84B 59.06M Jun/2026
Cigna USD 42.62B 410M Jun/2026
Coloplast 13.8B 2.32B Dec/2025
Convatec Group USD 1.69B 34M Dec/2024
CVS Health USD 79.7B 2.25B Jun/2026
Diasorin EUR 1.53B 151.64M Jun/2025
Elevance Health USD 44.88B 981M Jun/2026
General Electric Aerospace USD 17.64B 417M Jun/2026
Gulf Medical Proj AED 1.09B 135.31M Mar/2026
Humana USD 19.21B 633M Jun/2026
IQVIA Holdings USD 6.17B 50M Jun/2026
Laboratory Of America USD 8.61B 121.8M Jun/2026
Maximus USD 1.74B 43.59M Jun/2026
McKesson USD -4.24B 2.07B Jun/2026
Med Life RON 568M 84.24M Mar/2026
Molina Healthcare USD 4.17B 91M Jun/2026
Omnicell USD 1.29B 34.97M Jun/2026
Oriola-kd EUR 92.8M 8M Mar/2026
Owens Minor USD -550.94M 86.17M Jun/2026
Quest Diagnostics USD 7.52B 150M Jun/2026
Rede D'or Sao Luiz BRL 20.73B 1.6B Jun/2026
Siemens Healthineers EUR 19.1B 889M Jun/2026
Sonova Holding CHF 2.66B 374.5M Jun/2025
Supermax Corporation Bhd MYR 3.77B 44.17M Mar/2026
UnitedHealth USD 105.32B 3.62B Mar/2026
Veeva Systems USD 7.3B 89.6M Mar/2026
Veradigm USD 1.02B 159.52M Dec/2022
Xerox USD 323M 24M Jun/2026